Treatment with α-Galactosylceramide Attenuates the Development of Bleomycin-Induced Pulmonary Fibrosis

Journal of Immunology

Volumn 172, Issue 9, 2004, Pages 5782-5789

  Kimura, Toru ^a   Ishii, Yukio ^a   Morishima, Yuko ^a   Shibuya, Akira ^a,b,c   Shibuya, Kazuko ^a,b   Taniguchi, Masaru ^b,d   Mochizuki, Mie ^a   Hegab, Ahmed E ^a   Sakamoto, Tohru ^a   Nomura, Akihiro ^a   Sekizawa, Kiyohisa ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b RIKEN   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; BLEOMYCIN; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; LUNG FIBROSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SURVIVAL TIME;

EID: 11144355910     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.9.5782     Document Type: Article

References (39)

1. Liu, X., T. Kohyama, H. Wang, Y. K. Zhu, F. Q. Wen, H. J. Kim, D. J. Romberger, and S. I. Rennard. 2002. Th2 cytokine regulation of type I collagen gel contraction mediated by human lung mesenchymal cells. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L1049.
2. Postlethwaite, A. E., M. A. Holness, H. Katai, and R. Raghow. 1992. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest. 90:1479.
3. Sempowski, G. D., S. Derdak, and R. P. Phipps. 1996. Interleukin-4 and interferon-γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J. Cell. Physiol. 167:290.
4. Gurujeyalakshmi, G., and S. N. Giri. 1995. Molecular mechanisms of antifibrotic effect of interferon-γ in bleomycin-mouse model of lung fibrosis: downregulation of TGF-β and procollagen I and III gene expression. Exp. Lung Res. 21:791.
5. Hyde, D. M., T. S. Henderson, S. N. Giri, N. K. Tyler, and M. Y. Stovall. 1988. Effect of murine γ interferon on the cellular responses to bleomycin in mice. Exp. Lung Res. 14:687.
6. Saito, A., H. Okazaki, I. Sugawara, K. Yamamoto, and H. Takizawa. 2003. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int. Arch. Allergy Immunol. 132:168.
7. + T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285.
8. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159:2240.
9. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E, Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1626.
10. Hameg, A., I. Apostolou, M. Leite De Moraes, J. M. Gombert, C. Garcia, Y. Koezuka, J. F. Bach, and A. Herbelin. 2000. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the α-galactosylceramide antigen. J. Immunol. 165:4917.
11. Smyth, M. J., N. Y. Crowe, Y. Hayakawa, K. Takeda, H. Yagita, and D. I. Godfrey. 2002. NKT cells: conductors of tumor immunity? Curr. Opin. Immunol. 14:165.
12. Apostolou, I., Y. Takahama, C. Belmant, T. Kawano, M. Huerre, G. Marchal, J. Cui, M. Taniguchi, H. Nakauchi, J. J. Fournie, et al. 1999. Murine natural killer T (NKT) cells (correction of natural killer cells) contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA 96:5141.
13. + natural killer T cells by a-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69:213.
14. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
15. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
16. Guler, M. L., J. D. Gorham, C. S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984.
17. Adamson, I. Y., and D. H. Bowden. 1974. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77:185.
18. Snider, G. L., J. A. Hayes, and A. L. Korthy. 1978. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. Am. Rev. Respir. Dis. 117:1099.
19. Sleijfer, S. 2001. Bleomycin-induced pneumonitis. Chest 120:617.
20. Crystal, R. G., J. D. Fulmer, W. C. Roberts, M. L. Moss, B. R. Line, and H. Y. Reynolds. 1976. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann. Intern. Med. 85:769.
21. Ashcroft, T., J. M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41:467.
22. Woessner, L. F. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys. 93:440.
23. Murphy, E., K. Shibuya, N. Hosken, P. Openshaw, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:901.
24. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, et al. 1998. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA 95:5690.
25. Chandler, D. B., D. M. Hyde, and S. N. Giri. 1983. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters, Am. J. Pathol. 112:170.
26. Thrall, R. S., and R. W. Barton. 1984. A comparison of lymphocyte populations in lung tissue and in bronchoalveolar lavage fluid of rats at various times during the development of bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 129:279.
27. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655.
28. Schrier, D. J., S. H. Phan, and B. M. McGarry. 1983. The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis: a biochemical evaluation. Am. Rev. Respir. Dis. 127:614.
29. Szapiel, S. V., N. A. Elson, J. D. Fulmer, G. W. Hunninghake, and R. G. Crystal. 1979. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis. 120:893.
30. Helene, M., V. Lake, Bullock, J. Zhu, H. Hao, D. A. Cohen, and A. M. Kaplan. 1999. T cell independence of bleomycin-induced pulmonary fibrosis. J. Leukocyte Biol. 65:187.
31. Giri, S. N., D. M. Hyde, and M. A. Hollinger. 1993. Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax 48:959.
32. Lasky, J. A., L. A. Ortiz, B. Tonthat, G. W. Hoyle, M. Corti, G. Athas, G. Lungarella, A. Brody, and M. Friedman. 1998. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am. J. Physiol. 275:L365.
33. Grotendorst, G. R., H. Okochi, and N. Hayashi. 1996. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7:469.
34. Driscoll, K. E. 1994. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp. Lung Res. 20:473.
35. + natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur. J. Immunol. 33:3322.
36. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
37. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. L. Delovitch, J. M. Gombert, et al. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type I diabetes. Nat. Med. 7:1057.
38. Singh, N., S. Hong, D. C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer. 1999. Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163:2373.
39. Loehrer, Sr., P. J., D. Johnson, P. Elson, L. H. Einhom, and D. Trump. 1995. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. J. Clin. Oncol. 13:470.